Aqdot Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

Aqdot General Information

Description

Operator of a supramolecular chemistry company intended to serve the home care, beauty, and pet care industries. The company develops encapsulation technology that enables valuable active products to be protected, delivered, and chemically programmed to release where and when required, enabling businesses to capture and remove odors and pollutants, and release fragrances when triggered.

Contact Information

Website
www.aqdot.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 2 Iconix Park
  • London Road
  • Cambridge CB22 3EG
  • England, United Kingdom
+44 01223
Primary Industry
Specialty Chemicals
Other Industries
Other Chemicals and Gases
Corporate Office
  • Unit 2 Iconix Park
  • London Road
  • Cambridge CB22 3EG
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aqdot Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Secondary Transaction - Private Completed Generating Revenue
18. Accelerator/Incubator Completed Generating Revenue
17. Later Stage VC 20-Nov-2021 Completed Generating Revenue
16. Grant 01-Dec-2020 Completed Generating Revenue
15. Grant 01-Jun-2020 Completed Generating Revenue
14. Grant 01-May-2019 Completed Generating Revenue
13. Later Stage VC (Series B) 17-Apr-2019 Completed Generating Revenue
12. Grant 31-Aug-2018 Completed Generating Revenue
11. Grant 20-Jun-2018 $58.4K $12.9M Completed Generating Revenue
10. Grant 01-Jul-2017 $885K $12.9M Completed Generating Revenue
To view Aqdot’s complete valuation and funding history, request access »

Aqdot Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred shares
Preferred shares
EIS
Preferred shares
Preferred shares
EIS
EIS
Preferred shares
EIS 16,216 $0.013583 $12.56 $12.56 1x $12.56 0.68%
Preferred shares 89,190 $0.013583 $12.56 $12.56 1x $12.56 3.72%
To view Aqdot’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aqdot Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a supramolecular chemistry company intended to serve the home care, beauty, and pet care industries. The com
Specialty Chemicals
Cambridge, United Kingdom
20 As of 2026

Cedar City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aqdot Competitors (1)

One of Aqdot’s competitors is American Pacific, a Formerly PE-Backed company based in Cedar City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
American Pacific Formerly PE-Backed Cedar City, UT
You’re viewing 1 of 1 competitors. Get the full list »

Aqdot Patents

Aqdot Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202508963-D0 Supramolecular complexes Pending 06-Jun-2025
GB-202408407-D0 Cucurbituril formulation Inactive 12-Jun-2024
GB-202218667-D0 Cucurbituril formulation Inactive 12-Dec-2022
GB-202300544-D0 Cucurbituril formulation Inactive 12-Dec-2022
AU-2021356234-A1 A method for reducing allergens Pending 07-Oct-2020 A61K31/4188
To view Aqdot’s complete patent history, request access »

Aqdot Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aqdot Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
BGF (Financial Services) Growth/Expansion Minority
Clariant International Corporation Minority
Ingevity Corporation Minority
Plug and Play Accelerator/Incubator Minority
Horizon 2020 Government
You’re viewing 5 of 11 investors. Get the full list »

Aqdot FAQs

  • When was Aqdot founded?

    Aqdot was founded in 2012.

  • Where is Aqdot headquartered?

    Aqdot is headquartered in Cambridge, United Kingdom.

  • What is the size of Aqdot?

    Aqdot has 20 total employees.

  • What industry is Aqdot in?

    Aqdot’s primary industry is Specialty Chemicals.

  • Is Aqdot a private or public company?

    Aqdot is a Private company.

  • What is Aqdot’s current revenue?

    The current revenue for Aqdot is .

  • How much funding has Aqdot raised over time?

    Aqdot has raised $38.8M.

  • Who are Aqdot’s investors?

    BGF (Financial Services), Clariant International, Ingevity, Plug and Play, and Horizon 2020 are 5 of 11 investors who have invested in Aqdot.

  • Who are Aqdot’s competitors?

    American Pacific is a competitor of Aqdot.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process